IP Library Granted Patent US 10,702,565
Granted Patent B2
US 10,702,565 · App. 16/510,479 · Granted Jul 7, 2020

Tobacco products with cannabinoid additives and methods for reducing the harm associated with tobacco use

Inventors: Eric Greenbaum (New York, NY); Kyle Kingsley (Minneapolis, MN)
Assignee: RESURGENT PHARMACEUTICALS, INC.
A61K36/185A24B3/12A24B15/302A24B15/303A24D1/002A24D3/14A61K31/047A61K31/352A61K2236/37A61K2236/39
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,702,565
App. No.
16/510,479
Granted
Jul 7, 2020
Kind
B2
Abstract

A substantially pure fraction of at least one cannabinoid is added to smokable or smokeless tobacco products to reduce the harm associated with tobacco use. The harm to be reduced includes irritation and carcinogenicity of tobacco. In a preferred embodiment a whole plant cannabis extract is mixed directly with the tobacco during the curing or manufacturing process. For cigarette applications the cannabinoids may be inserted into a cigarette filter, and/or paper. In other embodiments the cannabinoids are purified.

Claims (2)

1. A method for reducing the harmful effects of tobacco use in a human in need thereof consisting essentially of administering to the human in need thereof tobacco and an isolated cannabinoid from cannabis to effectively reduce the harmful effects of tobacco use in the human in need thereof, wherein said cannabinoid is selected from the group consisting of tetrahydrocannabinol, cannabidiol and mixtures thereof and wherein said tobacco is in a form selected from the group consisting of cigarettes, cigars, chewing tobacco, and moist snuff.

2. The method of claim 1 , wherein the tetrahydrocannabinol and cannabidiol are present in a ratio of about 1:20, tetrahydrocannabinol: cannabidiol, when used as a mixture.

Assignments (5)
SECURITY INTEREST Recorded Jul 15, 2025
From: VIREO HEALTH, INC.; VIREO HEALTH OF MINNESOTA, LLC; WHOLESOMECO, INC.; DEEP ROOTS HARVEST, INC.; DEEP ROOTS ARIA ACQCO, INC.; RESURGENT BIOSCIENCES, INC.; NEW GROWTH HORIZON, LLC
To: CHICAGO ATLANTIC ADMIN, LLC
Reel/Frame 071709/0176 →
SECURITY INTEREST Recorded Jul 8, 2025
From: RESURGENT BIOSCIENCES, INC.; DEEP ROOTS HARVEST, INC.; DEEP ROOTS ARIA ACQCO, INC.; VIREO HEALTH, INC.; VIREO HEALTH OF MINNESOTA, LLC; WHOLESOMECO, INC.; NEW GROWTH HORIZON, LLC
To: EAST WEST BANK
Reel/Frame 071841/0350 →
CHANGE OF NAME Recorded Jul 1, 2025
From: RESURGENT PHARMACEUTICALS, INC.
To: RESURGENT BIOSCIENCES, INC.
Reel/Frame 071800/0905 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 22, 2023
From: GREENBAUM, ERIC; KINGSLEY, KYLE
To: RESURGENT BIOSCIENCES, INC
Reel/Frame 062768/0123 →
SECURITY INTEREST Recorded Mar 25, 2021
From: VIREO HEALTH INTERNATIONAL, INC.
To: CHICAGO ATLANTIC ADMIN, LLC
Reel/Frame 055721/0544 →
Continuity (3)
Continuation 15451377 · Mar 6, 2017
Provisional Application 62304276 · Mar 6, 2016
Related Publication 20190328807A1 · Oct 31, 2019